Skip to content
2414000682 / 6937092331 Παναγούλη 10, Λάρισα info@koufakis-diabetes.gr

The effects of sodium-glucose cotransporter 2 inhibitors beyond the cardio-renal-metabolic spectrum: Will gliflozins have a different fate than statins?

Δρ. Κουφάκης Θεοχάρης

Back To Top